Brief: Aileron Therapeutics Posts Quarterly Loss Per Share Of $0.06
11/08/2021 22:38
Aug 11 (Reuters) - Aileron Therapeutics Inc ALRN.O :
* AILERON THERAPEUTICS REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* AILERON THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.06
Source text for Eikon: ID:nGNX3MX8Yr
Further company coverage: ALRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering